[Oxytocin in cesarean-sections. What's new?]. / Ocitocina em cesarianas. O que há de novo?
Rev Bras Anestesiol
; 66(4): 402-7, 2016.
Article
em Pt
| MEDLINE
| ID: mdl-26626317
Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10 IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
Pt
Revista:
Rev Bras Anestesiol
Ano de publicação:
2016
Tipo de documento:
Article